SCRIP Interview Conducted at JHVS 2024 Published

November 5, 2024

At the Japan Healthcare Venture Summit (JHVS) 2024, held from October 9 to 11, 2024 at Pacifico Yokohama,

our company was interviewed by SCRIP* , 

a pharmaceutical industry news service provided by Citeline,

and the interview has now been published.

(The article can be accessed via the link provided here.)

During the interview, our President & CEO Toshiro Morohoshi discussed 

our global development strategy and provided updates 

on SSO-001—one of our pipeline assets currently undergoing Phase IIa clinical trials

for osteoarthritis.

He also shared his perspectives on fostering the growth of biotech ventures in Japan,

drawing on insights from his professional career.

* Citeline's pharmaceutical industry news service